Machinery & Equipment
Global Pharma Continuous Granulation Market Research Report 2026
- Mar 17, 26
- ID: 741575
- Pages: 137
- Figures: 141
- Views: 4
This report delivers a comprehensive overview of the global Pharma Continuous Granulation market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharma Continuous Granulation. The Pharma Continuous Granulation market size, estimates, and forecasts are provided in terms of shipments (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharma Continuous Granulation market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharma Continuous Granulation manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
LB Bohle
GEA
LCI
LÖDIGE
Senieer
Thermo Fisher Scientific
Syntegon
Gericke
Bepex
EARTHTECHNICA
Glatt
FREUND
Chansemt
Segment by Type
Dry Method
Wet Method
by Application
Tablets
Capsules
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Egypt
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pharma Continuous Granulation manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Pharma Continuous Granulation production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Pharma Continuous Granulation consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
The report segments the global Pharma Continuous Granulation market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharma Continuous Granulation manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
LB Bohle
GEA
LCI
LÖDIGE
Senieer
Thermo Fisher Scientific
Syntegon
Gericke
Bepex
EARTHTECHNICA
Glatt
FREUND
Chansemt
Segment by Type
Dry Method
Wet Method
by Application
Tablets
Capsules
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Egypt
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pharma Continuous Granulation manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Pharma Continuous Granulation production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Pharma Continuous Granulation consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
1 Pharma Continuous Granulation Market Overview
1.1 Product Definition
1.2 Pharma Continuous Granulation by Type
1.2.1 Global Pharma Continuous Granulation Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Dry Method
1.2.3 Wet Method
1.3 Pharma Continuous Granulation by Application
1.3.1 Global Pharma Continuous Granulation Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pharma Continuous Granulation Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Pharma Continuous Granulation Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Pharma Continuous Granulation Production Estimates and Forecasts (2021–2032)
1.4.4 Global Pharma Continuous Granulation Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharma Continuous Granulation Production Market Share by Manufacturers (2021–2026)
2.2 Global Pharma Continuous Granulation Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Pharma Continuous Granulation, Industry Ranking, 2024 vs 2025
2.4 Global Pharma Continuous Granulation Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Pharma Continuous Granulation Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Pharma Continuous Granulation, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Pharma Continuous Granulation, Product Offerings and Applications
2.8 Global Key Manufacturers of Pharma Continuous Granulation, Date of Entry into the Industry
2.9 Pharma Continuous Granulation Market Competitive Situation and Trends
2.9.1 Pharma Continuous Granulation Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Pharma Continuous Granulation Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Pharma Continuous Granulation Production by Region
3.1 Global Pharma Continuous Granulation Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Pharma Continuous Granulation Production Value by Region (2021–2032)
3.2.1 Global Pharma Continuous Granulation Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Pharma Continuous Granulation by Region (2027–2032)
3.3 Global Pharma Continuous Granulation Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Pharma Continuous Granulation Production Volume by Region (2021–2032)
3.4.1 Global Pharma Continuous Granulation Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Pharma Continuous Granulation by Region (2027–2032)
3.5 Global Pharma Continuous Granulation Market Price Analysis by Region (2021–2026)
3.6 Global Pharma Continuous Granulation Production, Value, and Year-over-Year Growth
3.6.1 North America Pharma Continuous Granulation Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Pharma Continuous Granulation Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Pharma Continuous Granulation Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Pharma Continuous Granulation Production Value Estimates and Forecasts (2021–2032)
4 Pharma Continuous Granulation Consumption by Region
4.1 Global Pharma Continuous Granulation Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Pharma Continuous Granulation Consumption by Region (2021–2032)
4.2.1 Global Pharma Continuous Granulation Consumption by Region (2021–2026)
4.2.2 Global Pharma Continuous Granulation Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Pharma Continuous Granulation Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Pharma Continuous Granulation Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharma Continuous Granulation Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Pharma Continuous Granulation Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Pharma Continuous Granulation Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharma Continuous Granulation Production by Type (2021–2032)
5.1.1 Global Pharma Continuous Granulation Production by Type (2021–2026)
5.1.2 Global Pharma Continuous Granulation Production by Type (2027–2032)
5.1.3 Global Pharma Continuous Granulation Production Market Share by Type (2021–2032)
5.2 Global Pharma Continuous Granulation Production Value by Type (2021–2032)
5.2.1 Global Pharma Continuous Granulation Production Value by Type (2021–2026)
5.2.2 Global Pharma Continuous Granulation Production Value by Type (2027–2032)
5.2.3 Global Pharma Continuous Granulation Production Value Market Share by Type (2021–2032)
5.3 Global Pharma Continuous Granulation Price by Type (2021–2032)
6 Segment by Application
6.1 Global Pharma Continuous Granulation Production by Application (2021–2032)
6.1.1 Global Pharma Continuous Granulation Production by Application (2021–2026)
6.1.2 Global Pharma Continuous Granulation Production by Application (2027–2032)
6.1.3 Global Pharma Continuous Granulation Production Market Share by Application (2021–2032)
6.2 Global Pharma Continuous Granulation Production Value by Application (2021–2032)
6.2.1 Global Pharma Continuous Granulation Production Value by Application (2021–2026)
6.2.2 Global Pharma Continuous Granulation Production Value by Application (2027–2032)
6.2.3 Global Pharma Continuous Granulation Production Value Market Share by Application (2021–2032)
6.3 Global Pharma Continuous Granulation Price by Application (2021–2032)
7 Key Companies Profiled
7.1 LB Bohle
7.1.1 LB Bohle Pharma Continuous Granulation Company Information
7.1.2 LB Bohle Pharma Continuous Granulation Product Portfolio
7.1.3 LB Bohle Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 LB Bohle Main Business and Markets Served
7.1.5 LB Bohle Recent Developments/Updates
7.2 GEA
7.2.1 GEA Pharma Continuous Granulation Company Information
7.2.2 GEA Pharma Continuous Granulation Product Portfolio
7.2.3 GEA Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 GEA Main Business and Markets Served
7.2.5 GEA Recent Developments/Updates
7.3 LCI
7.3.1 LCI Pharma Continuous Granulation Company Information
7.3.2 LCI Pharma Continuous Granulation Product Portfolio
7.3.3 LCI Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 LCI Main Business and Markets Served
7.3.5 LCI Recent Developments/Updates
7.4 LÖDIGE
7.4.1 LÖDIGE Pharma Continuous Granulation Company Information
7.4.2 LÖDIGE Pharma Continuous Granulation Product Portfolio
7.4.3 LÖDIGE Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 LÖDIGE Main Business and Markets Served
7.4.5 LÖDIGE Recent Developments/Updates
7.5 Senieer
7.5.1 Senieer Pharma Continuous Granulation Company Information
7.5.2 Senieer Pharma Continuous Granulation Product Portfolio
7.5.3 Senieer Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Senieer Main Business and Markets Served
7.5.5 Senieer Recent Developments/Updates
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Pharma Continuous Granulation Company Information
7.6.2 Thermo Fisher Scientific Pharma Continuous Granulation Product Portfolio
7.6.3 Thermo Fisher Scientific Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Thermo Fisher Scientific Main Business and Markets Served
7.6.5 Thermo Fisher Scientific Recent Developments/Updates
7.7 Syntegon
7.7.1 Syntegon Pharma Continuous Granulation Company Information
7.7.2 Syntegon Pharma Continuous Granulation Product Portfolio
7.7.3 Syntegon Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Syntegon Main Business and Markets Served
7.7.5 Syntegon Recent Developments/Updates
7.8 Gericke
7.8.1 Gericke Pharma Continuous Granulation Company Information
7.8.2 Gericke Pharma Continuous Granulation Product Portfolio
7.8.3 Gericke Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Gericke Main Business and Markets Served
7.8.5 Gericke Recent Developments/Updates
7.9 Bepex
7.9.1 Bepex Pharma Continuous Granulation Company Information
7.9.2 Bepex Pharma Continuous Granulation Product Portfolio
7.9.3 Bepex Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Bepex Main Business and Markets Served
7.9.5 Bepex Recent Developments/Updates
7.10 EARTHTECHNICA
7.10.1 EARTHTECHNICA Pharma Continuous Granulation Company Information
7.10.2 EARTHTECHNICA Pharma Continuous Granulation Product Portfolio
7.10.3 EARTHTECHNICA Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 EARTHTECHNICA Main Business and Markets Served
7.10.5 EARTHTECHNICA Recent Developments/Updates
7.11 Glatt
7.11.1 Glatt Pharma Continuous Granulation Company Information
7.11.2 Glatt Pharma Continuous Granulation Product Portfolio
7.11.3 Glatt Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Glatt Main Business and Markets Served
7.11.5 Glatt Recent Developments/Updates
7.12 FREUND
7.12.1 FREUND Pharma Continuous Granulation Company Information
7.12.2 FREUND Pharma Continuous Granulation Product Portfolio
7.12.3 FREUND Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 FREUND Main Business and Markets Served
7.12.5 FREUND Recent Developments/Updates
7.13 Chansemt
7.13.1 Chansemt Pharma Continuous Granulation Company Information
7.13.2 Chansemt Pharma Continuous Granulation Product Portfolio
7.13.3 Chansemt Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Chansemt Main Business and Markets Served
7.13.5 Chansemt Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharma Continuous Granulation Industry Chain Analysis
8.2 Pharma Continuous Granulation Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharma Continuous Granulation Production Modes and Processes
8.4 Pharma Continuous Granulation Sales and Marketing
8.4.1 Pharma Continuous Granulation Sales Channels
8.4.2 Pharma Continuous Granulation Distributors
8.5 Pharma Continuous Granulation Customer Analysis
9 Pharma Continuous Granulation Market Dynamics
9.1 Pharma Continuous Granulation Industry Trends
9.2 Pharma Continuous Granulation Market Drivers
9.3 Pharma Continuous Granulation Market Challenges
9.4 Pharma Continuous Granulation Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
1.1 Product Definition
1.2 Pharma Continuous Granulation by Type
1.2.1 Global Pharma Continuous Granulation Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Dry Method
1.2.3 Wet Method
1.3 Pharma Continuous Granulation by Application
1.3.1 Global Pharma Continuous Granulation Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pharma Continuous Granulation Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Pharma Continuous Granulation Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Pharma Continuous Granulation Production Estimates and Forecasts (2021–2032)
1.4.4 Global Pharma Continuous Granulation Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharma Continuous Granulation Production Market Share by Manufacturers (2021–2026)
2.2 Global Pharma Continuous Granulation Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Pharma Continuous Granulation, Industry Ranking, 2024 vs 2025
2.4 Global Pharma Continuous Granulation Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Pharma Continuous Granulation Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Pharma Continuous Granulation, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Pharma Continuous Granulation, Product Offerings and Applications
2.8 Global Key Manufacturers of Pharma Continuous Granulation, Date of Entry into the Industry
2.9 Pharma Continuous Granulation Market Competitive Situation and Trends
2.9.1 Pharma Continuous Granulation Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Pharma Continuous Granulation Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Pharma Continuous Granulation Production by Region
3.1 Global Pharma Continuous Granulation Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Pharma Continuous Granulation Production Value by Region (2021–2032)
3.2.1 Global Pharma Continuous Granulation Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Pharma Continuous Granulation by Region (2027–2032)
3.3 Global Pharma Continuous Granulation Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Pharma Continuous Granulation Production Volume by Region (2021–2032)
3.4.1 Global Pharma Continuous Granulation Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Pharma Continuous Granulation by Region (2027–2032)
3.5 Global Pharma Continuous Granulation Market Price Analysis by Region (2021–2026)
3.6 Global Pharma Continuous Granulation Production, Value, and Year-over-Year Growth
3.6.1 North America Pharma Continuous Granulation Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Pharma Continuous Granulation Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Pharma Continuous Granulation Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Pharma Continuous Granulation Production Value Estimates and Forecasts (2021–2032)
4 Pharma Continuous Granulation Consumption by Region
4.1 Global Pharma Continuous Granulation Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Pharma Continuous Granulation Consumption by Region (2021–2032)
4.2.1 Global Pharma Continuous Granulation Consumption by Region (2021–2026)
4.2.2 Global Pharma Continuous Granulation Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Pharma Continuous Granulation Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Pharma Continuous Granulation Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharma Continuous Granulation Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Pharma Continuous Granulation Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Pharma Continuous Granulation Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharma Continuous Granulation Production by Type (2021–2032)
5.1.1 Global Pharma Continuous Granulation Production by Type (2021–2026)
5.1.2 Global Pharma Continuous Granulation Production by Type (2027–2032)
5.1.3 Global Pharma Continuous Granulation Production Market Share by Type (2021–2032)
5.2 Global Pharma Continuous Granulation Production Value by Type (2021–2032)
5.2.1 Global Pharma Continuous Granulation Production Value by Type (2021–2026)
5.2.2 Global Pharma Continuous Granulation Production Value by Type (2027–2032)
5.2.3 Global Pharma Continuous Granulation Production Value Market Share by Type (2021–2032)
5.3 Global Pharma Continuous Granulation Price by Type (2021–2032)
6 Segment by Application
6.1 Global Pharma Continuous Granulation Production by Application (2021–2032)
6.1.1 Global Pharma Continuous Granulation Production by Application (2021–2026)
6.1.2 Global Pharma Continuous Granulation Production by Application (2027–2032)
6.1.3 Global Pharma Continuous Granulation Production Market Share by Application (2021–2032)
6.2 Global Pharma Continuous Granulation Production Value by Application (2021–2032)
6.2.1 Global Pharma Continuous Granulation Production Value by Application (2021–2026)
6.2.2 Global Pharma Continuous Granulation Production Value by Application (2027–2032)
6.2.3 Global Pharma Continuous Granulation Production Value Market Share by Application (2021–2032)
6.3 Global Pharma Continuous Granulation Price by Application (2021–2032)
7 Key Companies Profiled
7.1 LB Bohle
7.1.1 LB Bohle Pharma Continuous Granulation Company Information
7.1.2 LB Bohle Pharma Continuous Granulation Product Portfolio
7.1.3 LB Bohle Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 LB Bohle Main Business and Markets Served
7.1.5 LB Bohle Recent Developments/Updates
7.2 GEA
7.2.1 GEA Pharma Continuous Granulation Company Information
7.2.2 GEA Pharma Continuous Granulation Product Portfolio
7.2.3 GEA Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 GEA Main Business and Markets Served
7.2.5 GEA Recent Developments/Updates
7.3 LCI
7.3.1 LCI Pharma Continuous Granulation Company Information
7.3.2 LCI Pharma Continuous Granulation Product Portfolio
7.3.3 LCI Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 LCI Main Business and Markets Served
7.3.5 LCI Recent Developments/Updates
7.4 LÖDIGE
7.4.1 LÖDIGE Pharma Continuous Granulation Company Information
7.4.2 LÖDIGE Pharma Continuous Granulation Product Portfolio
7.4.3 LÖDIGE Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 LÖDIGE Main Business and Markets Served
7.4.5 LÖDIGE Recent Developments/Updates
7.5 Senieer
7.5.1 Senieer Pharma Continuous Granulation Company Information
7.5.2 Senieer Pharma Continuous Granulation Product Portfolio
7.5.3 Senieer Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Senieer Main Business and Markets Served
7.5.5 Senieer Recent Developments/Updates
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Pharma Continuous Granulation Company Information
7.6.2 Thermo Fisher Scientific Pharma Continuous Granulation Product Portfolio
7.6.3 Thermo Fisher Scientific Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Thermo Fisher Scientific Main Business and Markets Served
7.6.5 Thermo Fisher Scientific Recent Developments/Updates
7.7 Syntegon
7.7.1 Syntegon Pharma Continuous Granulation Company Information
7.7.2 Syntegon Pharma Continuous Granulation Product Portfolio
7.7.3 Syntegon Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Syntegon Main Business and Markets Served
7.7.5 Syntegon Recent Developments/Updates
7.8 Gericke
7.8.1 Gericke Pharma Continuous Granulation Company Information
7.8.2 Gericke Pharma Continuous Granulation Product Portfolio
7.8.3 Gericke Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Gericke Main Business and Markets Served
7.8.5 Gericke Recent Developments/Updates
7.9 Bepex
7.9.1 Bepex Pharma Continuous Granulation Company Information
7.9.2 Bepex Pharma Continuous Granulation Product Portfolio
7.9.3 Bepex Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Bepex Main Business and Markets Served
7.9.5 Bepex Recent Developments/Updates
7.10 EARTHTECHNICA
7.10.1 EARTHTECHNICA Pharma Continuous Granulation Company Information
7.10.2 EARTHTECHNICA Pharma Continuous Granulation Product Portfolio
7.10.3 EARTHTECHNICA Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 EARTHTECHNICA Main Business and Markets Served
7.10.5 EARTHTECHNICA Recent Developments/Updates
7.11 Glatt
7.11.1 Glatt Pharma Continuous Granulation Company Information
7.11.2 Glatt Pharma Continuous Granulation Product Portfolio
7.11.3 Glatt Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Glatt Main Business and Markets Served
7.11.5 Glatt Recent Developments/Updates
7.12 FREUND
7.12.1 FREUND Pharma Continuous Granulation Company Information
7.12.2 FREUND Pharma Continuous Granulation Product Portfolio
7.12.3 FREUND Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 FREUND Main Business and Markets Served
7.12.5 FREUND Recent Developments/Updates
7.13 Chansemt
7.13.1 Chansemt Pharma Continuous Granulation Company Information
7.13.2 Chansemt Pharma Continuous Granulation Product Portfolio
7.13.3 Chansemt Pharma Continuous Granulation Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Chansemt Main Business and Markets Served
7.13.5 Chansemt Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharma Continuous Granulation Industry Chain Analysis
8.2 Pharma Continuous Granulation Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharma Continuous Granulation Production Modes and Processes
8.4 Pharma Continuous Granulation Sales and Marketing
8.4.1 Pharma Continuous Granulation Sales Channels
8.4.2 Pharma Continuous Granulation Distributors
8.5 Pharma Continuous Granulation Customer Analysis
9 Pharma Continuous Granulation Market Dynamics
9.1 Pharma Continuous Granulation Industry Trends
9.2 Pharma Continuous Granulation Market Drivers
9.3 Pharma Continuous Granulation Market Challenges
9.4 Pharma Continuous Granulation Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Pharma Continuous Granulation Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pharma Continuous Granulation Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pharma Continuous Granulation Production Capacity (K Units) by Manufacturers in 2025
Table 4. Global Pharma Continuous Granulation Production by Manufacturers (K Units), 2021–2026
Table 5. Global Pharma Continuous Granulation Production Market Share by Manufacturers (2021–2026)
Table 6. Global Pharma Continuous Granulation Production Value by Manufacturers (US$ Million), 2021–2026
Table 7. Global Pharma Continuous Granulation Production Value Share by Manufacturers (2021–2026)
Table 8. Global Key Players of Pharma Continuous Granulation, Industry Ranking, 2024 vs 2025
Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharma Continuous Granulation Production Value, 2025
Table 10. Global Market Pharma Continuous Granulation Average Price by Manufacturers (US$/Unit), 2021–2026
Table 11. Global Key Manufacturers of Pharma Continuous Granulation, Manufacturing Footprints and Headquarters
Table 12. Global Key Manufacturers of Pharma Continuous Granulation, Product Offerings and Applications
Table 13. Global Key Manufacturers of Pharma Continuous Granulation, Date of Entry into the Industry
Table 14. Global Pharma Continuous Granulation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Pharma Continuous Granulation Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Pharma Continuous Granulation Production Value (US$ Million) by Region (2021–2026)
Table 18. Global Pharma Continuous Granulation Production Value Market Share by Region (2021–2026)
Table 19. Global Pharma Continuous Granulation Production Value (US$ Million) Forecast by Region (2027–2032)
Table 20. Global Pharma Continuous Granulation Production Value Market Share Forecast by Region (2027–2032)
Table 21. Global Pharma Continuous Granulation Production Comparison by Region: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Pharma Continuous Granulation Production (K Units) by Region (2021–2026)
Table 23. Global Pharma Continuous Granulation Production Market Share by Region (2021–2026)
Table 24. Global Pharma Continuous Granulation Production (K Units) Forecast by Region (2027–2032)
Table 25. Global Pharma Continuous Granulation Production Market Share Forecast by Region (2027–2032)
Table 26. Global Pharma Continuous Granulation Market Average Price (US$/Unit) by Region (2021–2026)
Table 27. Global Pharma Continuous Granulation Market Average Price (US$/Unit) by Region (2027–2032)
Table 28. Global Pharma Continuous Granulation Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Units)
Table 29. Global Pharma Continuous Granulation Consumption by Region (K Units), 2021–2026
Table 30. Global Pharma Continuous Granulation Consumption Market Share by Region (2021–2026)
Table 31. Global Pharma Continuous Granulation Forecasted Consumption by Region (K Units), 2027–2032
Table 32. Global Pharma Continuous Granulation Forecasted Consumption Market Share by Region (2027–2032)
Table 33. North America Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 34. North America Pharma Continuous Granulation Consumption by Country (K Units), 2021–2026
Table 35. North America Pharma Continuous Granulation Consumption by Country (K Units), 2027–2032
Table 36. Europe Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 37. Europe Pharma Continuous Granulation Consumption by Country (K Units), 2021–2026
Table 38. Europe Pharma Continuous Granulation Consumption by Country (K Units), 2027–2032
Table 39. Asia Pacific Pharma Continuous Granulation Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Units)
Table 40. Asia Pacific Pharma Continuous Granulation Consumption by Region (K Units), 2021–2026
Table 41. Asia Pacific Pharma Continuous Granulation Consumption by Region (K Units), 2027–2032
Table 42. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 43. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption by Country (K Units), 2021–2026
Table 44. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption by Country (K Units), 2027–2032
Table 45. Global Pharma Continuous Granulation Production (K Units) by Type (2021–2026)
Table 46. Global Pharma Continuous Granulation Production (K Units) by Type (2027–2032)
Table 47. Global Pharma Continuous Granulation Production Market Share by Type (2021–2026)
Table 48. Global Pharma Continuous Granulation Production Market Share by Type (2027–2032)
Table 49. Global Pharma Continuous Granulation Production Value (US$ Million) by Type (2021–2026)
Table 50. Global Pharma Continuous Granulation Production Value (US$ Million) by Type (2027–2032)
Table 51. Global Pharma Continuous Granulation Production Value Market Share by Type (2021–2026)
Table 52. Global Pharma Continuous Granulation Production Value Market Share by Type (2027–2032)
Table 53. Global Pharma Continuous Granulation Price (US$/Unit) by Type (2021–2026)
Table 54. Global Pharma Continuous Granulation Price (US$/Unit) by Type (2027–2032)
Table 55. Global Pharma Continuous Granulation Production (K Units) by Application (2021–2026)
Table 56. Global Pharma Continuous Granulation Production (K Units) by Application (2027–2032)
Table 57. Global Pharma Continuous Granulation Production Market Share by Application (2021–2026)
Table 58. Global Pharma Continuous Granulation Production Market Share by Application (2027–2032)
Table 59. Global Pharma Continuous Granulation Production Value (US$ Million) by Application (2021–2026)
Table 60. Global Pharma Continuous Granulation Production Value (US$ Million) by Application (2027–2032)
Table 61. Global Pharma Continuous Granulation Production Value Market Share by Application (2021–2026)
Table 62. Global Pharma Continuous Granulation Production Value Market Share by Application (2027–2032)
Table 63. Global Pharma Continuous Granulation Price (US$/Unit) by Application (2021–2026)
Table 64. Global Pharma Continuous Granulation Price (US$/Unit) by Application (2027–2032)
Table 65. LB Bohle Pharma Continuous Granulation Company Information
Table 66. LB Bohle Pharma Continuous Granulation Specification and Application
Table 67. LB Bohle Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 68. LB Bohle Main Business and Markets Served
Table 69. LB Bohle Recent Developments/Updates
Table 70. GEA Pharma Continuous Granulation Company Information
Table 71. GEA Pharma Continuous Granulation Specification and Application
Table 72. GEA Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 73. GEA Main Business and Markets Served
Table 74. GEA Recent Developments/Updates
Table 75. LCI Pharma Continuous Granulation Company Information
Table 76. LCI Pharma Continuous Granulation Specification and Application
Table 77. LCI Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 78. LCI Main Business and Markets Served
Table 79. LCI Recent Developments/Updates
Table 80. LÖDIGE Pharma Continuous Granulation Company Information
Table 81. LÖDIGE Pharma Continuous Granulation Specification and Application
Table 82. LÖDIGE Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 83. LÖDIGE Main Business and Markets Served
Table 84. LÖDIGE Recent Developments/Updates
Table 85. Senieer Pharma Continuous Granulation Company Information
Table 86. Senieer Pharma Continuous Granulation Specification and Application
Table 87. Senieer Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 88. Senieer Main Business and Markets Served
Table 89. Senieer Recent Developments/Updates
Table 90. Thermo Fisher Scientific Pharma Continuous Granulation Company Information
Table 91. Thermo Fisher Scientific Pharma Continuous Granulation Specification and Application
Table 92. Thermo Fisher Scientific Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 93. Thermo Fisher Scientific Main Business and Markets Served
Table 94. Thermo Fisher Scientific Recent Developments/Updates
Table 95. Syntegon Pharma Continuous Granulation Company Information
Table 96. Syntegon Pharma Continuous Granulation Specification and Application
Table 97. Syntegon Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 98. Syntegon Main Business and Markets Served
Table 99. Syntegon Recent Developments/Updates
Table 100. Gericke Pharma Continuous Granulation Company Information
Table 101. Gericke Pharma Continuous Granulation Specification and Application
Table 102. Gericke Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 103. Gericke Main Business and Markets Served
Table 104. Gericke Recent Developments/Updates
Table 105. Bepex Pharma Continuous Granulation Company Information
Table 106. Bepex Pharma Continuous Granulation Specification and Application
Table 107. Bepex Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 108. Bepex Main Business and Markets Served
Table 109. Bepex Recent Developments/Updates
Table 110. EARTHTECHNICA Pharma Continuous Granulation Company Information
Table 111. EARTHTECHNICA Pharma Continuous Granulation Specification and Application
Table 112. EARTHTECHNICA Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 113. EARTHTECHNICA Main Business and Markets Served
Table 114. EARTHTECHNICA Recent Developments/Updates
Table 115. Glatt Pharma Continuous Granulation Company Information
Table 116. Glatt Pharma Continuous Granulation Specification and Application
Table 117. Glatt Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 118. Glatt Main Business and Markets Served
Table 119. Glatt Recent Developments/Updates
Table 120. FREUND Pharma Continuous Granulation Company Information
Table 121. FREUND Pharma Continuous Granulation Specification and Application
Table 122. FREUND Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 123. FREUND Main Business and Markets Served
Table 124. FREUND Recent Developments/Updates
Table 125. Chansemt Pharma Continuous Granulation Company Information
Table 126. Chansemt Pharma Continuous Granulation Specification and Application
Table 127. Chansemt Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 128. Chansemt Main Business and Markets Served
Table 129. Chansemt Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Pharma Continuous Granulation Distributors List
Table 133. Pharma Continuous Granulation Customers List
Table 134. Pharma Continuous Granulation Market Trends
Table 135. Pharma Continuous Granulation Market Drivers
Table 136. Pharma Continuous Granulation Market Challenges
Table 137. Pharma Continuous Granulation Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharma Continuous Granulation
Figure 2. Global Pharma Continuous Granulation Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pharma Continuous Granulation Market Share by Type: 2025 vs 2032
Figure 4. Dry Method Product Picture
Figure 5. Wet Method Product Picture
Figure 6. Global Pharma Continuous Granulation Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Pharma Continuous Granulation Market Share by Application: 2025 vs 2032
Figure 8. Tablets
Figure 9. Capsules
Figure 10. Others
Figure 11. Global Pharma Continuous Granulation Production Value (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Pharma Continuous Granulation Production Value (US$ Million), 2021–2032
Figure 13. Global Pharma Continuous Granulation Production Capacity (K Units), 2021–2032
Figure 14. Global Pharma Continuous Granulation Production (K Units), 2021–2032
Figure 15. Global Pharma Continuous Granulation Average Price (US$/Unit), 2021–2032
Figure 16. Pharma Continuous Granulation Report Years Considered
Figure 17. Pharma Continuous Granulation Production Share by Manufacturers in 2025
Figure 18. Global Pharma Continuous Granulation Production Value Share by Manufacturers (2025)
Figure 19. Pharma Continuous Granulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Top 5 and Top 10 Global Players: Market Share by Pharma Continuous Granulation Revenue in 2025
Figure 21. Global Pharma Continuous Granulation Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 22. Global Pharma Continuous Granulation Production Value Market Share by Region: 2021 vs 2025 vs 2032
Figure 23. Global Pharma Continuous Granulation Production Comparison by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 24. Global Pharma Continuous Granulation Production Market Share by Region: 2021 vs 2025 vs 2032
Figure 25. North America Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2021–2032)
Figure 26. Europe Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2021–2032)
Figure 27. China Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2021–2032)
Figure 28. Japan Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2021–2032)
Figure 29. Global Pharma Continuous Granulation Consumption by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 30. Global Pharma Continuous Granulation Consumption Market Share by Region: 2021 vs 2025 vs 2032
Figure 31. North America Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 32. North America Pharma Continuous Granulation Consumption Market Share by Country (2021–2032)
Figure 33. U.S. Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 34. Canada Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 35. Europe Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 36. Europe Pharma Continuous Granulation Consumption Market Share by Country (2021–2032)
Figure 37. Germany Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 38. France Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 39. U.K. Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 40. Italy Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 41. Russia Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 42. Asia Pacific Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 43. Asia Pacific Pharma Continuous Granulation Consumption Market Share by Region (2021–2032)
Figure 44. China Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 45. Japan Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 46. South Korea Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 47. China Taiwan Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 48. Southeast Asia Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 49. India Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 50. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 51. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption Market Share by Country (2021–2032)
Figure 52. Mexico Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 53. Brazil Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 54. Turkey Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 55. GCC Countries Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 56. Global Production Market Share of Pharma Continuous Granulation by Type (2021–2032)
Figure 57. Global Production Value Market Share of Pharma Continuous Granulation by Type (2021–2032)
Figure 58. Global Pharma Continuous Granulation Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Production Market Share of Pharma Continuous Granulation by Application (2021–2032)
Figure 60. Global Production Value Market Share of Pharma Continuous Granulation by Application (2021–2032)
Figure 61. Global Pharma Continuous Granulation Price (US$/Unit) by Application (2021–2032)
Figure 62. Pharma Continuous Granulation Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Table 1. Global Pharma Continuous Granulation Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pharma Continuous Granulation Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pharma Continuous Granulation Production Capacity (K Units) by Manufacturers in 2025
Table 4. Global Pharma Continuous Granulation Production by Manufacturers (K Units), 2021–2026
Table 5. Global Pharma Continuous Granulation Production Market Share by Manufacturers (2021–2026)
Table 6. Global Pharma Continuous Granulation Production Value by Manufacturers (US$ Million), 2021–2026
Table 7. Global Pharma Continuous Granulation Production Value Share by Manufacturers (2021–2026)
Table 8. Global Key Players of Pharma Continuous Granulation, Industry Ranking, 2024 vs 2025
Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharma Continuous Granulation Production Value, 2025
Table 10. Global Market Pharma Continuous Granulation Average Price by Manufacturers (US$/Unit), 2021–2026
Table 11. Global Key Manufacturers of Pharma Continuous Granulation, Manufacturing Footprints and Headquarters
Table 12. Global Key Manufacturers of Pharma Continuous Granulation, Product Offerings and Applications
Table 13. Global Key Manufacturers of Pharma Continuous Granulation, Date of Entry into the Industry
Table 14. Global Pharma Continuous Granulation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Pharma Continuous Granulation Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Pharma Continuous Granulation Production Value (US$ Million) by Region (2021–2026)
Table 18. Global Pharma Continuous Granulation Production Value Market Share by Region (2021–2026)
Table 19. Global Pharma Continuous Granulation Production Value (US$ Million) Forecast by Region (2027–2032)
Table 20. Global Pharma Continuous Granulation Production Value Market Share Forecast by Region (2027–2032)
Table 21. Global Pharma Continuous Granulation Production Comparison by Region: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Pharma Continuous Granulation Production (K Units) by Region (2021–2026)
Table 23. Global Pharma Continuous Granulation Production Market Share by Region (2021–2026)
Table 24. Global Pharma Continuous Granulation Production (K Units) Forecast by Region (2027–2032)
Table 25. Global Pharma Continuous Granulation Production Market Share Forecast by Region (2027–2032)
Table 26. Global Pharma Continuous Granulation Market Average Price (US$/Unit) by Region (2021–2026)
Table 27. Global Pharma Continuous Granulation Market Average Price (US$/Unit) by Region (2027–2032)
Table 28. Global Pharma Continuous Granulation Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Units)
Table 29. Global Pharma Continuous Granulation Consumption by Region (K Units), 2021–2026
Table 30. Global Pharma Continuous Granulation Consumption Market Share by Region (2021–2026)
Table 31. Global Pharma Continuous Granulation Forecasted Consumption by Region (K Units), 2027–2032
Table 32. Global Pharma Continuous Granulation Forecasted Consumption Market Share by Region (2027–2032)
Table 33. North America Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 34. North America Pharma Continuous Granulation Consumption by Country (K Units), 2021–2026
Table 35. North America Pharma Continuous Granulation Consumption by Country (K Units), 2027–2032
Table 36. Europe Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 37. Europe Pharma Continuous Granulation Consumption by Country (K Units), 2021–2026
Table 38. Europe Pharma Continuous Granulation Consumption by Country (K Units), 2027–2032
Table 39. Asia Pacific Pharma Continuous Granulation Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Units)
Table 40. Asia Pacific Pharma Continuous Granulation Consumption by Region (K Units), 2021–2026
Table 41. Asia Pacific Pharma Continuous Granulation Consumption by Region (K Units), 2027–2032
Table 42. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 43. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption by Country (K Units), 2021–2026
Table 44. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption by Country (K Units), 2027–2032
Table 45. Global Pharma Continuous Granulation Production (K Units) by Type (2021–2026)
Table 46. Global Pharma Continuous Granulation Production (K Units) by Type (2027–2032)
Table 47. Global Pharma Continuous Granulation Production Market Share by Type (2021–2026)
Table 48. Global Pharma Continuous Granulation Production Market Share by Type (2027–2032)
Table 49. Global Pharma Continuous Granulation Production Value (US$ Million) by Type (2021–2026)
Table 50. Global Pharma Continuous Granulation Production Value (US$ Million) by Type (2027–2032)
Table 51. Global Pharma Continuous Granulation Production Value Market Share by Type (2021–2026)
Table 52. Global Pharma Continuous Granulation Production Value Market Share by Type (2027–2032)
Table 53. Global Pharma Continuous Granulation Price (US$/Unit) by Type (2021–2026)
Table 54. Global Pharma Continuous Granulation Price (US$/Unit) by Type (2027–2032)
Table 55. Global Pharma Continuous Granulation Production (K Units) by Application (2021–2026)
Table 56. Global Pharma Continuous Granulation Production (K Units) by Application (2027–2032)
Table 57. Global Pharma Continuous Granulation Production Market Share by Application (2021–2026)
Table 58. Global Pharma Continuous Granulation Production Market Share by Application (2027–2032)
Table 59. Global Pharma Continuous Granulation Production Value (US$ Million) by Application (2021–2026)
Table 60. Global Pharma Continuous Granulation Production Value (US$ Million) by Application (2027–2032)
Table 61. Global Pharma Continuous Granulation Production Value Market Share by Application (2021–2026)
Table 62. Global Pharma Continuous Granulation Production Value Market Share by Application (2027–2032)
Table 63. Global Pharma Continuous Granulation Price (US$/Unit) by Application (2021–2026)
Table 64. Global Pharma Continuous Granulation Price (US$/Unit) by Application (2027–2032)
Table 65. LB Bohle Pharma Continuous Granulation Company Information
Table 66. LB Bohle Pharma Continuous Granulation Specification and Application
Table 67. LB Bohle Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 68. LB Bohle Main Business and Markets Served
Table 69. LB Bohle Recent Developments/Updates
Table 70. GEA Pharma Continuous Granulation Company Information
Table 71. GEA Pharma Continuous Granulation Specification and Application
Table 72. GEA Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 73. GEA Main Business and Markets Served
Table 74. GEA Recent Developments/Updates
Table 75. LCI Pharma Continuous Granulation Company Information
Table 76. LCI Pharma Continuous Granulation Specification and Application
Table 77. LCI Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 78. LCI Main Business and Markets Served
Table 79. LCI Recent Developments/Updates
Table 80. LÖDIGE Pharma Continuous Granulation Company Information
Table 81. LÖDIGE Pharma Continuous Granulation Specification and Application
Table 82. LÖDIGE Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 83. LÖDIGE Main Business and Markets Served
Table 84. LÖDIGE Recent Developments/Updates
Table 85. Senieer Pharma Continuous Granulation Company Information
Table 86. Senieer Pharma Continuous Granulation Specification and Application
Table 87. Senieer Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 88. Senieer Main Business and Markets Served
Table 89. Senieer Recent Developments/Updates
Table 90. Thermo Fisher Scientific Pharma Continuous Granulation Company Information
Table 91. Thermo Fisher Scientific Pharma Continuous Granulation Specification and Application
Table 92. Thermo Fisher Scientific Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 93. Thermo Fisher Scientific Main Business and Markets Served
Table 94. Thermo Fisher Scientific Recent Developments/Updates
Table 95. Syntegon Pharma Continuous Granulation Company Information
Table 96. Syntegon Pharma Continuous Granulation Specification and Application
Table 97. Syntegon Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 98. Syntegon Main Business and Markets Served
Table 99. Syntegon Recent Developments/Updates
Table 100. Gericke Pharma Continuous Granulation Company Information
Table 101. Gericke Pharma Continuous Granulation Specification and Application
Table 102. Gericke Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 103. Gericke Main Business and Markets Served
Table 104. Gericke Recent Developments/Updates
Table 105. Bepex Pharma Continuous Granulation Company Information
Table 106. Bepex Pharma Continuous Granulation Specification and Application
Table 107. Bepex Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 108. Bepex Main Business and Markets Served
Table 109. Bepex Recent Developments/Updates
Table 110. EARTHTECHNICA Pharma Continuous Granulation Company Information
Table 111. EARTHTECHNICA Pharma Continuous Granulation Specification and Application
Table 112. EARTHTECHNICA Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 113. EARTHTECHNICA Main Business and Markets Served
Table 114. EARTHTECHNICA Recent Developments/Updates
Table 115. Glatt Pharma Continuous Granulation Company Information
Table 116. Glatt Pharma Continuous Granulation Specification and Application
Table 117. Glatt Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 118. Glatt Main Business and Markets Served
Table 119. Glatt Recent Developments/Updates
Table 120. FREUND Pharma Continuous Granulation Company Information
Table 121. FREUND Pharma Continuous Granulation Specification and Application
Table 122. FREUND Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 123. FREUND Main Business and Markets Served
Table 124. FREUND Recent Developments/Updates
Table 125. Chansemt Pharma Continuous Granulation Company Information
Table 126. Chansemt Pharma Continuous Granulation Specification and Application
Table 127. Chansemt Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 128. Chansemt Main Business and Markets Served
Table 129. Chansemt Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Pharma Continuous Granulation Distributors List
Table 133. Pharma Continuous Granulation Customers List
Table 134. Pharma Continuous Granulation Market Trends
Table 135. Pharma Continuous Granulation Market Drivers
Table 136. Pharma Continuous Granulation Market Challenges
Table 137. Pharma Continuous Granulation Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharma Continuous Granulation
Figure 2. Global Pharma Continuous Granulation Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pharma Continuous Granulation Market Share by Type: 2025 vs 2032
Figure 4. Dry Method Product Picture
Figure 5. Wet Method Product Picture
Figure 6. Global Pharma Continuous Granulation Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Pharma Continuous Granulation Market Share by Application: 2025 vs 2032
Figure 8. Tablets
Figure 9. Capsules
Figure 10. Others
Figure 11. Global Pharma Continuous Granulation Production Value (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Pharma Continuous Granulation Production Value (US$ Million), 2021–2032
Figure 13. Global Pharma Continuous Granulation Production Capacity (K Units), 2021–2032
Figure 14. Global Pharma Continuous Granulation Production (K Units), 2021–2032
Figure 15. Global Pharma Continuous Granulation Average Price (US$/Unit), 2021–2032
Figure 16. Pharma Continuous Granulation Report Years Considered
Figure 17. Pharma Continuous Granulation Production Share by Manufacturers in 2025
Figure 18. Global Pharma Continuous Granulation Production Value Share by Manufacturers (2025)
Figure 19. Pharma Continuous Granulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Top 5 and Top 10 Global Players: Market Share by Pharma Continuous Granulation Revenue in 2025
Figure 21. Global Pharma Continuous Granulation Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 22. Global Pharma Continuous Granulation Production Value Market Share by Region: 2021 vs 2025 vs 2032
Figure 23. Global Pharma Continuous Granulation Production Comparison by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 24. Global Pharma Continuous Granulation Production Market Share by Region: 2021 vs 2025 vs 2032
Figure 25. North America Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2021–2032)
Figure 26. Europe Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2021–2032)
Figure 27. China Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2021–2032)
Figure 28. Japan Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2021–2032)
Figure 29. Global Pharma Continuous Granulation Consumption by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 30. Global Pharma Continuous Granulation Consumption Market Share by Region: 2021 vs 2025 vs 2032
Figure 31. North America Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 32. North America Pharma Continuous Granulation Consumption Market Share by Country (2021–2032)
Figure 33. U.S. Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 34. Canada Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 35. Europe Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 36. Europe Pharma Continuous Granulation Consumption Market Share by Country (2021–2032)
Figure 37. Germany Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 38. France Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 39. U.K. Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 40. Italy Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 41. Russia Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 42. Asia Pacific Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 43. Asia Pacific Pharma Continuous Granulation Consumption Market Share by Region (2021–2032)
Figure 44. China Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 45. Japan Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 46. South Korea Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 47. China Taiwan Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 48. Southeast Asia Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 49. India Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 50. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 51. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption Market Share by Country (2021–2032)
Figure 52. Mexico Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 53. Brazil Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 54. Turkey Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 55. GCC Countries Pharma Continuous Granulation Consumption and Growth Rate (K Units), 2021–2032
Figure 56. Global Production Market Share of Pharma Continuous Granulation by Type (2021–2032)
Figure 57. Global Production Value Market Share of Pharma Continuous Granulation by Type (2021–2032)
Figure 58. Global Pharma Continuous Granulation Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Production Market Share of Pharma Continuous Granulation by Application (2021–2032)
Figure 60. Global Production Value Market Share of Pharma Continuous Granulation by Application (2021–2032)
Figure 61. Global Pharma Continuous Granulation Price (US$/Unit) by Application (2021–2032)
Figure 62. Pharma Continuous Granulation Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232